Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Hilsden

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Patient Education and Counseling|October 8, 2003
Complementary therapies: evaluating their effectiveness in cancerR J Hilsden, M J Verhoef
Canadian Family Physician Medecin De Famille Canadien|November 1, 1995
Management of gastrointestinal hemorrhageR J Hilsden, E A Shaffer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 15, 1996
Cholecystectomy also on rise in AlbertaR J Hilsden, E A Shaffer
Inflammatory Bowel Diseases|December 4, 1998
Complementary and alternative medicine: evaluating its effectiveness in inflammatory bowel diseaseR J Hilsden, M J Verhoef
BMC Medical Research Methodology|January 22, 2002
Determinants of abstract acceptance for the Digestive Diseases Week--a cross sectional studyA Timmer, R J Hilsden, L R Sutherland
Patient Education and Counseling|October 8, 2003
Complementary therapies and cancer care: an overviewM J Verhoef, R J Hilsden, M O'Beirne
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 9, 1999
Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet surveyR J Hilsden, J B Meddings, M J Verhoef
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 12, 2005
Qualitative research in inflammatory bowel disease: dispelling the myths of an unknown entityL C Vanderheyden, M J Verhoef, R J Hilsden
Complementary Therapies in Medicine|April 2, 2003
Inflammatory bowel disease patients' decisions to use complementary therapies: links to existing models of careC M Scott, M J Verhoef, R J Hilsden
Arthritis and Rheumatism|July 1, 1995
End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiencyR J Hilsden, S J Urbanski, M G Swain
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Patient Education and Counseling|October 8, 2003
Complementary therapies: evaluating their effectiveness in cancerR J Hilsden, M J Verhoef
Canadian Family Physician Medecin De Famille Canadien|November 1, 1995
Management of gastrointestinal hemorrhageR J Hilsden, E A Shaffer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 15, 1996
Cholecystectomy also on rise in AlbertaR J Hilsden, E A Shaffer
Inflammatory Bowel Diseases|December 4, 1998
Complementary and alternative medicine: evaluating its effectiveness in inflammatory bowel diseaseR J Hilsden, M J Verhoef
BMC Medical Research Methodology|January 22, 2002
Determinants of abstract acceptance for the Digestive Diseases Week--a cross sectional studyA Timmer, R J Hilsden, L R Sutherland
Patient Education and Counseling|October 8, 2003
Complementary therapies and cancer care: an overviewM J Verhoef, R J Hilsden, M O'Beirne
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|June 9, 1999
Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet surveyR J Hilsden, J B Meddings, M J Verhoef
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 12, 2005
Qualitative research in inflammatory bowel disease: dispelling the myths of an unknown entityL C Vanderheyden, M J Verhoef, R J Hilsden
Complementary Therapies in Medicine|April 2, 2003
Inflammatory bowel disease patients' decisions to use complementary therapies: links to existing models of careC M Scott, M J Verhoef, R J Hilsden
Arthritis and Rheumatism|July 1, 1995
End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiencyR J Hilsden, S J Urbanski, M G Swain
Pageof 3